Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
BioXcel Therapeutics Inc (NASDAQ: BTAI) closed the day trading at $0.36 down -7.06% from the previous closing price of $0.38. In other words, the price has decreased by -$7.06 from its previous closing price. On the day, 0.59 million shares were traded. BTAI stock price reached its highest trading level at $0.3925 during the session, while it also had its lowest trading level at $0.35.
Ratios:
For a better understanding of BTAI, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.81 and its Current Ratio is at 1.87.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, UBS on February 21, 2024, Downgraded its rating to Neutral and sets its target price to $4 from $9 previously.
On August 15, 2023, Mizuho Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $40 to $4.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 16 ’24 when O’Neill Vincent sold 165 shares for $0.35 per share. The transaction valued at 58 led to the insider holds 19,957 shares of the business.
Mehta Vimal sold 3,117 shares of BTAI for $1,131 on Dec 16 ’24. The CEO and President now owns 59,605 shares after completing the transaction at $0.36 per share. On Dec 16 ’24, another insider, Steinhart Richard I, who serves as the Chief Financial Officer of the company, sold 577 shares for $0.36 each. As a result, the insider received 207 and left with 20,932 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BTAI now has a Market Capitalization of 17702628 and an Enterprise Value of 68555056. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.77. Its current Enterprise Value per Revenue stands at 28.529 whereas that against EBITDA is -0.657.
Stock Price History:
Over the past 52 weeks, BTAI has reached a high of $4.17, while it has fallen to a 52-week low of $0.30. The 50-Day Moving Average of the stock is -25.73%, while the 200-Day Moving Average is calculated to be -68.31%.
Shares Statistics:
Over the past 3-months, BTAI traded about 839.18K shares per day on average, while over the past 10 days, BTAI traded about 1719440 shares per day. A total of 42.46M shares are outstanding, with a floating share count of 41.08M. Insiders hold about 17.23% of the company’s shares, while institutions hold 17.38% stake in the company. Shares short for BTAI as of 1730332800 were 347081 with a Short Ratio of 0.96, compared to 1727654400 on 516384. Therefore, it implies a Short% of Shares Outstanding of 347081 and a Short% of Float of 1.09.
